Delivery Order SPE2DB22D6029-SPE2DB25FLVWA
Award Date 9/4/25
Potential Completion Date 9/5/25
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,356.57 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Docetaxel 160 mg/16 ml vials. This award represents a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,097.08 to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/4 mL vials. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries firm fixed pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Docetaxel 80 mg/4 mL vials valued at $1,093.69. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,574.73 for Docetaxel 160 mg/16 mL vials on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Docetaxel is a chemotherapy medication used primarily in cancer treatment protocols across military and federal...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 160 mg/16 ml vials of the drug Docetaxel, a chemotherapy medication used to treat various types of cancer. The contract has a ceiling value of $6,528.63 and a period of performance ending on July 10, 2025. It is a firm fixed-price contract, and there is no set-aside...
- The Defense Logistics Agency awarded a $8,649.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,049.10 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $4,467.19 to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,181.76 to AmerisourceBergen Drug Corp on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract for pharmaceutical products and medical supplies. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $33,521.05 to AmerisourceBergen Drug Corp on August 20, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order represents a non-competitive award issued under an existing contract vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...